1. Synthesis, structure and anticancer properties of new biotin- and morpholine-functionalized ruthenium and osmium half-sandwich complexes
- Author
-
Mickaël Marloye, François Dufrasne, Vinciane Debaille, Michel Gelbcke, Connor J. Moore, Haider Inam, Justin R. Pritchard, Franck Meyer, and Gilles Berger
- Subjects
Aquation ,chemistry.chemical_element ,010402 general chemistry ,01 natural sciences ,Biochemistry ,Inorganic Chemistry ,Anticancer complex ,chemistry.chemical_compound ,Cell targeting ,Biotin ,Morpholine ,medicine ,Osmium ,Chimie pharmaceutique ,biology ,Metallodrug ,010405 organic chemistry ,Chemistry ,Topoisomerase ,shRNA profiling ,Metal–arene ,Combinatorial chemistry ,0104 chemical sciences ,Ruthenium ,Chimie organique ,Mechanism of action ,biology.protein ,medicine.symptom ,Platinum - Abstract
Ruthenium (Ru) and osmium (Os) complexes are of sustained interest in cancer research and may be alternative to platinum-based therapy. We detail here three new series of ruthenium and osmium complexes, supported by physico-chemical characterizations, including time-dependent density functional theory, a combined experimental and computational study on the aquation reactions and the nature of the metal-arene bond. Cytotoxic profiles were then evaluated on several cancer cell lines although with limited success. Further investigations were, however, performed on the most active series using a genetic approach based on RNA interference and highlighted a potential multi-target mechanism of action through topoisomerase II, mitotic spindle, HDAC and DNMT inhibition., info:eu-repo/semantics/published
- Published
- 2021
- Full Text
- View/download PDF